🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

2 recruiting trials

for Non-small Cell Lung Caner

A Phase 2 Study of Luvometinib Combined With Anlotinib in KRAS-mutated NSCLC NCT07562581Phase 21 site📍 Shanghai Shanghai Fosun Pharmaceutical Industrial Development Co. Lt… · Tests: luvometinib + anlotinib, luvometinib + anlotinib Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More Treatment NCT05363280Phase 27 sites📍 Birmingham📍 Weston📍 Chicago Advenchen Pharmaceuticals, LLC. · Tests: AL8326 40 mg, AL8326 60 mg, AL8326 80 mg--stopped
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy